Skip to main content
. 2018 Sep 21;9:166–175. doi: 10.1016/j.ynstr.2018.09.001

Table 1.

Summary of the addictive properties of low-dose ketamine in rodents and molecular correlates. Female adolescent and adult rodents are more sensitive to the locomotor-activating effects of ketamine. The reinforcing properties of ketamine in females are mediated by the presence of ovarian hormones.

Sex Age Dose R.O.A. Treatment Regimen Behavioral Response Molecular Change References
Male Adult 100 μg per inf i.v. 1x/4 days ↑ FR1 self-administration n/a (Wright et al., 2017)
↑ cue-induced reinstatement
2.5 mg/kg i.p. 1x/2 days no change ↑NAc ΔfosB (Schoepfer et al., 2017)
Weekly no change ↑ NAc shell spines (Strong et al., 2017)
5 mg/kg i.p. Daily ↑ locomotor sensitization n/a (Botanas et al., 2015)
↑ CPP
1x/2 days ↑ locomotor sensitization ↑NAc ΔfosB (Schoepfer et al., 2017)
Weekly ↑ locomotor sensitization ↑ NAc ΔfosB (Strong et al., 2017)
↑ NAc GluA1
↑ NAc BDNF
↑ NAc CaMKIIα
↑ NAc shell spines
10 mg/kg i.p. Daily ↑ locomotor sensitization n/a (Wiley et al., 2008)
↑ CPP n/a (Li et al., 2008)
1x/2 days ↑ locomotor sensitization ↑ NAc ΔfosB (Schoepfer et al., 2017)
↑ CPP
Female Adult 100 μg per inf i.v. 1x/4 days ↑ FR1 self-administration (proestrous) n/a (Wright et al., 2017)
↑cue-induced reinstatement (proestrous)
↓FR1 self-administration (diestrous)
↓ cue-induced reinstatement (diestrous)
2.5 mg/kg i.p. 1x/2 days no change ↑NAc ΔfosB (Schoepfer et al., 2017)
Weekly ↑ locomotor sensitization (diestrous) ↑ NAc shell spines (Strong et al., 2017)
5 mg/kg i.p. 1x/2 days ↑ locomotor sensitization ↑NAc ΔfosB (Schoepfer et al., 2017)
↓ CPP
Weekly ↑ locomotor sensitization ↑ NAc GluA1 (Strong et al., 2017)
↓ CPP (diestrous) ↑ NAc core spines
↑ NAc shell spines
10 mg/kg i.p. Daily ↑ locomotor sensitization n/a (Wiley et al., 2011)
1x/2 days ↑ locomotor sensitization ↑NAc ΔfosB (Schoepfer et al., 2017)
Male Adolescent 10 mg/kg i.p. Daily no change n/a (Wiley et al., 2007)
20 mg/kg i.p. Daily ↑ locomotor sensitization no change in CPP n/a (Rocha et al., 2017)
n/a (Parise et al., 2013)
Female Adolescent 10 mg/kg i.p. Daily ↑ locomotor sensitization n/a (Wiley et al., 2011)

(inf = infusion; i.p. = intraperitoneal; CPP = conditioned place preference; NAc = nucleus accumbens; GluA1 = AMPA receptor 1; CaMKIIα = calcium calmodulin kinase II alpha).